Pharmaceutical Technology

JUNE 19, 2025

Actio Biosciences CEO and co-founder David Goldstein stated: “We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drug development. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 19, 2025

Kisunla and Leqembi were touted as the most promising treatments to emerge from Alzheimer’s drug development in recent times. However, side effects from the drugs can be serious, and their high cost has been a barrier to reimbursement. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 19, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network. Credit: Bohbeh creations/Shutterstock. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 24, 2025

June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Fluimucil IV is now available to patients across China as an essential hospital-based treatment for respiratory conditions. By GlobalData Learn more about Strategic Intelligence The Phase I study involved healthy volunteers and was conducted at Ruijin Hospital.

Hospitals

Pharmaceutical Technology

JUNE 24, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JUNE 19, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 24, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Compounding

Pharmaceutical Technology

JUNE 20, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Pharmaceutical Manufacturing

Pharmaceutical Technology

JUNE 20, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 20, 2025

In recent years, the pharmaceutical industry has exhibited a significant shift into digitalisation, with AI pushing for innovation across the entire drug development value chain, from accelerating drug discovery to optimising clinical trial design to ultimately improve patient outcomes.

Drug Development

Pharmaceutical Technology

JUNE 23, 2025

While health researchers were well-aware of SDoH before COVID-19, the pandemic served as a reminder of their importance and highlighted how much work was still left to do in relieving health inequity.

Insurance Coverage and Processing

Pharmaceutical Technology

SEPTEMBER 15, 2022

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.

Research Laboratories

PharmaShots

FEBRUARY 27, 2023

As a renowned chemist, Dr. Senanayake discussed the need to adopt green chemistry in the process of drug development for cost reduction, timely innovation, and generating less waste than the standard process. facility for manufacturing biologics in his presentation. Anurag continued by presenting an overview of the next-gen.

Biosimilars

European Pharmaceutical Review

FEBRUARY 20, 2025

China and India together supply more than 70 percent of APIs used in US drug manufacturing, while Europe remains a key supplier of high-value biologics and specialised medicines. 3 Additionally, tariffs could increase lead times for manufacturing, as companies navigate customs barriers and seek alternative suppliers.

Generic Medicine